ALL BALLS 1999-2002 750SS DUCATI FITS KIT SEAL OIL FORK Motorcycle Fork Seals


  1. Home
  2. ALL BALLS 1999-2002 750SS DUCATI FITS KIT SEAL OIL FORK
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
ALL BALLS FORK OIL SEAL KIT FITS DUCATI 750SS 1999-2002
Condition: New Model/ Series: 750SS 1999-2002
Part Type: Fork Oil Seal Set Manufacturer: Ducati
Sub-Type: Shock Absorbers & Suspension Intended Use: Replacement Part
Type: Body & Frame Manufacturer Part Number:

55-120

MPN:

55-120

Brand:

All Balls

Part Subtype: Front Suspension Seal
published on tue nov 09 2021

ALL BALLS 1999-2002 750SS DUCATI FITS KIT SEAL OIL FORK Motorcycle Fork Seals

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

ALL BALLS 1999-2002 750SS DUCATI FITS KIT SEAL OIL FORK Motorcycle Fork Seals

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS